TRIB2
Tribbles homolog 2
Also known as: GS3955, TRB2, TRIB2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92519
- Gene
- TRIB2
- Ensembl
- ENSG00000071575
- Chromosome
- 2
- Canonical length
- 343 aa
- Protein class
- Enzymes, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes one of three members of the Tribbles family. The Tribbles members share a Trb domain, which is homologous to protein serine-threonine kinases, but lacks the active site lysine and probably lacks a catalytic function. The Tribbles proteins interact and modulate the activity of signal transduction pathways in a number of physiological and pathological processes. This Tribbles member induces apoptosis of cells mainly of the hematopoietic origin. It has been identified as a protein up-regulated by inflammatory stimuli in myeloid (THP-1) cells, and also as an oncogene that inactivates the transcription factor C/EBPalpha (CCAAT/enhancer-binding protein alpha) and causes acute myelogenous leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
Canonical amino-acid sequenceUniProt
343 residues, UniProt reviewed canonical sequence.
>Q92519|TRIB2
1 MNIHRSTPIT IARYGRSRNK TQDFEELSSI RSAEPSQSFS PNLGSPSPPE TPNLSHCVSC
61 IGKYLLLEPL EGDHVFRAVH LHSGEELVCK VFDISCYQES LAPCFCLSAH SNINQITEII
121 LGETKAYVFF ERSYGDMHSF VRTCKKLREE EAARLFYQIA SAVAHCHDGG LVLRDLKLRK
181 FIFKDEERTR VKLESLEDAY ILRGDDDSLS DKHGCPAYVS PEILNTSGSY SGKAADVWSL
241 GVMLYTMLVG RYPFHDIEPS SLFSKIRRGQ FNIPETLSPK AKCLIRSILR REPSERLTSQ
301 EILDHPWFST DFSVSNSAYG AKEVSDQLVP DVNMEENLDP FFNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIB2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 127 nTPM
Expression across tissuesHPA
Tissue
- retina: 127 nTPM
- ovary: 96 nTPM
- spleen: 77 nTPM
- kidney: 68 nTPM
- lymph node: 67 nTPM
- tonsil: 65 nTPM
Single-cell type
- bergmann glia: 230 nCPM
- melanocytes: 129 nCPM
- müller glia: 127 nCPM
- podocytes: 120 nCPM
- leydig cells: 102 nCPM
- peritubular myoid cells: 83 nCPM
Immune cell
- T-reg: 49 nTPM
- memory CD4 T-cell: 26 nTPM
- NK-cell: 19 nTPM
- MAIT T-cell: 16 nTPM
- naive CD4 T-cell: 15 nTPM
- memory CD8 T-cell: 14 nTPM
Brain region
- hypothalamus: 45 nTPM
- cerebellum: 42 nTPM
- cerebral cortex: 35 nTPM
- thalamus: 35 nTPM
- medulla oblongata: 33 nTPM
- midbrain: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRIB2.
Disease | ImmuneIEDB
Conditions an epitope on TRIB2 was assayed in.
- narcolepsy T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against TRIB2 are reported. Each links to that disease's full target list.
Showing 0 of 1 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for TRIB2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
10 publications
- Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
2010 · J Clin Invest · RCR 6 · 217 citations - Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.
2010 · Sleep · RCR 2.8 · 97 citations - Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?
2010 · Brain · RCR 2.1 · 72 citations - Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy.
2010 · Sleep · RCR 1.9 · 66 citations - Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice.
2013 · J Autoimmun · RCR 1.8 · 55 citations
Show 5 more
- A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
2014 · J Autoimmun · RCR 1.3 · 35 citations - Identification of tribbles homolog 2 as an autoantigen in autoimmune uveitis by phage display.
2005 · Mol Immunol · RCR 0.8 · 39 citations - Anti-Tribbles Pseudokinase 2 (TRIB2)-Immunization Modulates Hypocretin/Orexin Neuronal Functions.
2017 · Sleep · RCR 0.7 · 18 citations - Cell-based vs enzyme-linked immunosorbent assay for detection of anti-Tribbles homolog 2 autoantibodies in Chinese patients with narcolepsy.
2024 · J Clin Sleep Med · RCR 0.2 · 1 citations - Sleep: Narcolepsy--a role for TRIB2 autoantibodies?
2010 · Nat Rev Neurol · RCR 0 · 1 citations
Reference: T cellIEDB
2 publications
- T cells in patients with narcolepsy target self-antigens of hypocretin neurons.
2018 · Nature · RCR 9.5 · 249 citations - CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens.
2019 · Nat Commun · RCR 4.3 · 93 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 1.71
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of fat cell differentiation
- negative regulation of interleukin-10 production
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- regulation of MAP kinase activity
Molecular functions
- mitogen-activated protein kinase kinase binding
- protein kinase inhibitor activity
- RNA polymerase II-specific DNA-binding transcription factor binding
- ubiquitin protein ligase binding
- ubiquitin-protein transferase regulator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIB2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIB2 as an antibody target. Whether an autoantibody or antibody against TRIB2 could matter depends on whether native TRIB2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIB2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIB2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...